Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein.

Salvador B, Zhou Y, Michault A, Muench MO, Simmons G.

Virology. 2009 Oct 10;393(1):33-41. doi: 10.1016/j.virol.2009.07.013. Epub 2009 Aug 18.

2.

Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.

Kishishita N, Takeda N, Anuegoonpipat A, Anantapreecha S.

J Clin Microbiol. 2013 May;51(5):1389-95. doi: 10.1128/JCM.03109-12. Epub 2013 Feb 13.

3.

A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.

Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Mar;88(5):2385-97. doi: 10.1128/JVI.03116-13. Epub 2013 Dec 26.

5.

pH-dependent entry of chikungunya virus into Aedes albopictus cells.

Gay B, Bernard E, Solignat M, Chazal N, Devaux C, Briant L.

Infect Genet Evol. 2012 Aug;12(6):1275-81. doi: 10.1016/j.meegid.2012.02.003. Epub 2012 Feb 20.

PMID:
22386853
6.

Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence.

Tsetsarkin KA, Weaver SC.

PLoS Pathog. 2011 Dec;7(12):e1002412. doi: 10.1371/journal.ppat.1002412. Epub 2011 Dec 8.

7.

Molecular investigations of chikungunya virus during outbreaks in Orissa, Eastern India in 2010.

Das B, Sahu A, Das M, Patra A, Dwibedi B, Kar SK, Hazra RK.

Infect Genet Evol. 2012 Jul;12(5):1094-101. doi: 10.1016/j.meegid.2012.03.012. Epub 2012 Mar 29.

PMID:
22484761
8.

Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.

Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Nov;88(21):12180-92. doi: 10.1128/JVI.01672-14. Epub 2014 Aug 20.

9.

Cell-based analysis of Chikungunya virus E1 protein in membrane fusion.

Kuo SC, Chen YJ, Wang YM, Tsui PY, Kuo MD, Wu TY, Lo SJ.

J Biomed Sci. 2012 Apr 21;19:44. doi: 10.1186/1423-0127-19-44.

10.

Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells.

Metz SW, Geertsema C, Martina BE, Andrade P, Heldens JG, van Oers MM, Goldbach RW, Vlak JM, Pijlman GP.

Virol J. 2011 Jul 15;8:353. doi: 10.1186/1743-422X-8-353.

11.

Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein.

Arias-Goeta C, Moutailler S, Mousson L, Zouache K, Thiberge JM, Caro V, Rougeon F, Failloux AB.

Infect Genet Evol. 2014 Jun;24:116-26. doi: 10.1016/j.meegid.2014.03.015. Epub 2014 Mar 26.

PMID:
24681263
12.

A single mutation in chikungunya virus affects vector specificity and epidemic potential.

Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S.

PLoS Pathog. 2007 Dec;3(12):e201.

13.

Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.

Kumar P, Pok KY, Tan LK, Angela C, Leo YS, Ng LC.

J Virol Methods. 2014 Sep;206:67-75. doi: 10.1016/j.jviromet.2014.05.014. Epub 2014 May 29.

PMID:
24880071
14.

Chikungunya virus isolates with/without A226V mutation show different sensitivity to IFN-a, but similar replication kinetics in non human primate cells.

Bordi L, Meschi S, Selleri M, Lalle E, Castilletti C, Carletti F, Chiappini R, Di Caro A, Capobianchi MR.

New Microbiol. 2011 Jan;34(1):87-91. Epub 2011 Jan 15.

15.

Molecular characterization of Chikungunya virus isolates from clinical samples and adult Aedes albopictus mosquitoes emerged from larvae from Kerala, South India.

Niyas KP, Abraham R, Unnikrishnan RN, Mathew T, Nair S, Manakkadan A, Issac A, Sreekumar E.

Virol J. 2010 Aug 13;7:189. doi: 10.1186/1743-422X-7-189.

16.

A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK.

J Virol. 2013 Jan;87(1):395-402. doi: 10.1128/JVI.01860-12. Epub 2012 Oct 17.

17.

Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.

Acharya D, Paul AM, Anderson JF, Huang F, Bai F.

PLoS Negl Trop Dis. 2015 Oct 20;9(10):e0004139. doi: 10.1371/journal.pntd.0004139. eCollection 2015.

18.

Chikungunya virus glycoproteins pseudotype with lentiviral vectors and reveal a broad spectrum of cellular tropism.

Hu D, Zhang J, Wang H, Liu S, Yu L, Sun L, Qu Y.

PLoS One. 2014 Oct 21;9(10):e110893. doi: 10.1371/journal.pone.0110893. eCollection 2014.

19.

A226V mutation in virus during the 2007 chikungunya outbreak in Kerala, India.

Kumar NP, Joseph R, Kamaraj T, Jambulingam P.

J Gen Virol. 2008 Aug;89(Pt 8):1945-8. doi: 10.1099/vir.0.83628-0.

PMID:
18632966
20.

Differential regulation of TLR mediated innate immune response of mouse neuronal cells following infection with novel ECSA genotype of Chikungunya virus with and without E1:A226V mutation.

Priya R, Dhanwani R, Patro IK, Rao PV, Parida MM.

Infect Genet Evol. 2013 Dec;20:396-406. doi: 10.1016/j.meegid.2013.09.030. Epub 2013 Oct 12.

PMID:
24126361
Items per page

Supplemental Content

Write to the Help Desk